Studies have shown that the antiallergic drug Tranilast can inhibit the secretory function of fibroblasts in peritoneal metastatic GC tissue, effectively improve the tumor microenvironment, increase the infiltration of CD8+ T cells, as well as reduce the infiltration of M2 macrophages and mast cells. Here, CD8A is linked to neoplasm.